The world market for recombinant proteins remains strong, with North America and Europe dominating research and development as a result of their strong biopharmaceutical industries. The Asia-Pacific ...

A new article titled Self-Documenting Plasmids has been published in Trends in Biotechnology, introducing a breakthrough technology that could redefine the way plasmids are tracked, verified, and ...

Kendall Square has become a hub of biotech innovation and a popular location for up and coming life sciences firms. Now, a ...

Using phages and bacteria such as Escherichia coli to make ... piece of DNA), to form a composite known as recombinant DNA. Introducing this composite into a bacterial host cell allows the segment ...

Tonix halts major depression disorder drug after phase 2 failure The investigational therapy works as a recombinant protein ...

To save what’s left of nature, governments must follow through on their 2022 commitment to conserve 30% of the world’s land ...

ImmunityBio, Inc. faces stock decline amid fundraising and market selloff. Click to read more on the long-term potential of ...

Valneva will provide a live webcast of its first quarter 2025 results conference call beginning at 3 p.m. CEST/9 a.m. EDT today. This webcast will also be available on the Company’s website. Please ...

The major players in the veterinary medicine market are Zoetis, Inc., Merck & Co., Inc. (Intervet International B.V.), Elanco Animal Health, Dechra Pharmaceuticals PLC, Ceva Sante Animale, Virbac., ...

Recombinant hirudins, for example ... Enzymes derived from deep-sea bacteria have been used to make tests for COVID-19. The most undervalued creatures often hold the most miraculous secrets, but we ...

Traditionally, viruses have been thought of as a burden that cause disease. Now, viruses are being harnessed to tackle ...

According to the US' CDC, the ongoing clade II 2022 mpox outbreak has been responsible for over 100,000 infections in 122 countries to date worldwide.